H&R GMBH & CO KGAA (2HRA.DE) Stock Fundamental Analysis

FRA:2HRA • DE000A2E4T77

4.4 EUR
+0.06 (+1.38%)
Last: Feb 23, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, 2HRA scores 3 out of 10 in our fundamental rating. 2HRA was compared to 69 industry peers in the Chemicals industry. There are concerns on the financial health of 2HRA while its profitability can be described as average. 2HRA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year 2HRA was profitable.
  • In the past year 2HRA had a positive cash flow from operations.
  • 2HRA had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years 2HRA had a positive operating cash flow.
2HRA.DE Yearly Net Income VS EBIT VS OCF VS FCF2HRA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • 2HRA has a Return On Assets (0.40%) which is comparable to the rest of the industry.
  • 2HRA's Return On Equity of 0.95% is in line compared to the rest of the industry. 2HRA outperforms 42.03% of its industry peers.
  • 2HRA has a Return On Invested Capital (2.43%) which is in line with its industry peers.
  • 2HRA had an Average Return On Invested Capital over the past 3 years of 4.21%. This is below the industry average of 7.10%.
Industry RankSector Rank
ROA 0.4%
ROE 0.95%
ROIC 2.43%
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
2HRA.DE Yearly ROA, ROE, ROIC2HRA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • 2HRA's Profit Margin of 0.31% is on the low side compared to the rest of the industry. 2HRA is outperformed by 60.87% of its industry peers.
  • 2HRA's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 2.18%, 2HRA is not doing good in the industry: 63.77% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of 2HRA has grown nicely.
  • Looking at the Gross Margin, with a value of 24.46%, 2HRA is doing worse than 65.22% of the companies in the same industry.
  • 2HRA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.18%
PM (TTM) 0.31%
GM 24.46%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
2HRA.DE Yearly Profit, Operating, Gross Margins2HRA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2HRA is destroying value.
  • 2HRA has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 2HRA remains at a similar level compared to 5 years ago.
  • 2HRA has a better debt/assets ratio than last year.
2HRA.DE Yearly Shares Outstanding2HRA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
2HRA.DE Yearly Total Debt VS Total Assets2HRA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • 2HRA has an Altman-Z score of 2.12. This is not the best score and indicates that 2HRA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 2HRA's Altman-Z score of 2.12 is in line compared to the rest of the industry. 2HRA outperforms 43.48% of its industry peers.
  • 2HRA has a debt to FCF ratio of 33.63. This is a negative value and a sign of low solvency as 2HRA would need 33.63 years to pay back of all of its debts.
  • 2HRA has a Debt to FCF ratio (33.63) which is in line with its industry peers.
  • 2HRA has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • 2HRA has a better Debt to Equity ratio (0.13) than 76.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 33.63
Altman-Z 2.12
ROIC/WACC0.43
WACC5.65%
2HRA.DE Yearly LT Debt VS Equity VS FCF2HRA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • 2HRA has a Current Ratio of 1.42. This is a normal value and indicates that 2HRA is financially healthy and should not expect problems in meeting its short term obligations.
  • 2HRA has a Current ratio of 1.42. This is in the lower half of the industry: 2HRA underperforms 68.12% of its industry peers.
  • 2HRA has a Quick Ratio of 1.42. This is a bad value and indicates that 2HRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of 2HRA (0.75) is worse than 72.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.75
2HRA.DE Yearly Current Assets VS Current Liabilites2HRA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for 2HRA have decreased strongly by -30.03% in the last year.
  • Measured over the past years, 2HRA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -40.40% on average per year.
  • Looking at the last year, 2HRA shows a decrease in Revenue. The Revenue has decreased by -3.07% in the last year.
  • Measured over the past years, 2HRA shows a small growth in Revenue. The Revenue has been growing by 4.47% on average per year.
EPS 1Y (TTM)-30.03%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%-122.22%
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%-8.14%

3.2 Future

  • 2HRA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.54% yearly.
  • The Revenue is expected to decrease by -0.42% on average over the next years.
EPS Next Y-64.54%
EPS Next 2Y-9.3%
EPS Next 3Y2.54%
EPS Next 5YN/A
Revenue Next Year-5.19%
Revenue Next 2Y-1.92%
Revenue Next 3Y-0.42%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
2HRA.DE Yearly Revenue VS Estimates2HRA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
2HRA.DE Yearly EPS VS Estimates2HRA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 44.00, which means the current valuation is very expensive for 2HRA.
  • Based on the Price/Earnings ratio, 2HRA is valued a bit more expensive than 62.32% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.98, 2HRA is valued quite expensively.
  • The Price/Forward Earnings ratio is 22.31, which indicates a rather expensive current valuation of 2HRA.
  • The rest of the industry has a similar Price/Forward Earnings ratio as 2HRA.
  • When comparing the Price/Forward Earnings ratio of 2HRA to the average of the S&P500 Index (28.01), we can say 2HRA is valued slightly cheaper.
Industry RankSector Rank
PE 44
Fwd PE 22.31
2HRA.DE Price Earnings VS Forward Price Earnings2HRA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 2HRA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • 2HRA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 34.23
EV/EBITDA 2.59
2HRA.DE Per share data2HRA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.3%
EPS Next 3Y2.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.28%, 2HRA has a reasonable but not impressive dividend return.
  • 2HRA's Dividend Yield is a higher than the industry average which is at 2.23.
  • Compared to an average S&P500 Dividend Yield of 1.81, 2HRA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.28%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
2HRA.DE Yearly Dividends per share2HRA.DE Yearly Dividends per shareYearly Dividends per share 2018 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

  • 94.56% of the earnings are spent on dividend by 2HRA. This is not a sustainable payout ratio.
DP94.56%
EPS Next 2Y-9.3%
EPS Next 3Y2.54%
2HRA.DE Yearly Income VS Free CF VS Dividend2HRA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
2HRA.DE Dividend Payout.2HRA.DE Dividend Payout, showing the Payout Ratio.2HRA.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

H&R GMBH & CO KGAA

FRA:2HRA (2/23/2026, 7:00:00 PM)

4.4

+0.06 (+1.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)03-31
Inst Owners1.4%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap163.77M
Revenue(TTM)1.29B
Net Income(TTM)3.94M
Analysts36.36
Price Target4.69 (6.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.28%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP94.56%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.76%
PT rev (3m)-6.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-44.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 44
Fwd PE 22.31
P/S 0.13
P/FCF 34.23
P/OCF 2.51
P/B 0.4
P/tB 0.43
EV/EBITDA 2.59
EPS(TTM)0.1
EY2.27%
EPS(NY)0.2
Fwd EY4.48%
FCF(TTM)0.13
FCFY2.92%
OCF(TTM)1.76
OCFY39.92%
SpS34.61
BVpS11.09
TBVpS10.33
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5
Profitability
Industry RankSector Rank
ROA 0.4%
ROE 0.95%
ROCE 4.1%
ROIC 2.43%
ROICexc 2.75%
ROICexgc 2.88%
OM 2.18%
PM (TTM) 0.31%
GM 24.46%
FCFM 0.37%
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
ROICexc(3y)4.64%
ROICexc(5y)4.53%
ROICexgc(3y)4.9%
ROICexgc(5y)4.79%
ROCE(3y)7.11%
ROCE(5y)6.95%
ROICexgc growth 3Y-25.59%
ROICexgc growth 5Y22.95%
ROICexc growth 3Y-25.37%
ROICexc growth 5Y23.82%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 33.63
Debt/EBITDA 0.59
Cap/Depr 98.21%
Cap/Sales 4.7%
Interest Coverage 3.72
Cash Conversion 72.84%
Profit Quality 121.57%
Current Ratio 1.42
Quick Ratio 0.75
Altman-Z 2.12
F-Score5
WACC5.65%
ROIC/WACC0.43
Cap/Depr(3y)102.18%
Cap/Depr(5y)93.34%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.03%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%-122.22%
EPS Next Y-64.54%
EPS Next 2Y-9.3%
EPS Next 3Y2.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%-8.14%
Revenue Next Year-5.19%
Revenue Next 2Y-1.92%
Revenue Next 3Y-0.42%
Revenue Next 5YN/A
EBIT growth 1Y3.84%
EBIT growth 3Y-23.19%
EBIT growth 5Y31.47%
EBIT Next Year170.83%
EBIT Next 3Y44.32%
EBIT Next 5YN/A
FCF growth 1Y-94.25%
FCF growth 3YN/A
FCF growth 5Y-5.95%
OCF growth 1Y-56.02%
OCF growth 3Y23.36%
OCF growth 5Y-6.03%

H&R GMBH & CO KGAA / 2HRA.DE FAQ

Can you provide the ChartMill fundamental rating for H&R GMBH & CO KGAA?

ChartMill assigns a fundamental rating of 3 / 10 to 2HRA.DE.


What is the valuation status for 2HRA stock?

ChartMill assigns a valuation rating of 2 / 10 to H&R GMBH & CO KGAA (2HRA.DE). This can be considered as Overvalued.


Can you provide the profitability details for H&R GMBH & CO KGAA?

H&R GMBH & CO KGAA (2HRA.DE) has a profitability rating of 4 / 10.


What is the financial health of H&R GMBH & CO KGAA (2HRA.DE) stock?

The financial health rating of H&R GMBH & CO KGAA (2HRA.DE) is 3 / 10.


Can you provide the expected EPS growth for 2HRA stock?

The Earnings per Share (EPS) of H&R GMBH & CO KGAA (2HRA.DE) is expected to decline by -64.54% in the next year.